Drug Recall: Montreal Class Action Claim



[ad_1]





Valsartan is a drug used to treat patients with high blood pressure and to prevent heart attacks and strokes. It can also be taken by people who have recently had a heart attack or heart attack.


Courtesy of Hope Litoff

A clbad action suit filed Monday at the Montreal courthouse targets manufacturers of a cardiac drug. , Valsartan, to pay damages to Quebeckers who took the drug.

A reminder issued by Health Canada on July 9, 2018, announced that several drugs containing valsartan were contaminated with an impurity: a chemical called N-nitrosodimethylamine, NDMA

NDMA is a potential carcinogen for the drug. man, which means that his long-term exposure could cause cancer, according to the International Agency for Research on Cancer

Valsartan is a drug used to treat hypertensive patients. to prevent heart attacks and strokes. People who have recently suffered heart failure or heart attack also take this medication

. Health Canada has advised people taking drugs containing valsartan not to stop taking their medications, but to contact their pharmacist to inquire about the recall. In Canadian recalls, drugs containing valsartan have been recalled in 21 other countries due to contamination by the supplier: a Chinese company called Zhejiang Huahai Pharmaceutical

Kenneth Aitcheson, a man from Beaconsfield, is the plaintiff in the clbad action petition. If a judge gives OK for the clbad action, he will likely represent the other people taking part in the lawsuit.

In November 2016, Aitcheson started taking valsartan daily to regulate his blood pressure.

He claims to have been misled into believing that the drug could be safely consumed and that he stopped taking it on July 14, five days after Health Canada issued a recall for this drug

]. drugs containing valsartan of negligent behavior. He alleges that the companies failed to properly inspect the ingredients shipped from China and did not inform the people who took them that they were contaminated and subject to a recall.

"The members of the group suffered an injury because there is a future that clbad members contract cancer because they have consumed a drug contaminated with NDMA, which is a carcinogen, "indicates the claim.

It also states that the members of the group suffered damages, including loss of income, medical expenses,

The clbad action petition is presented on behalf of any person who has purchased or consumed the recalled products of valsartan.

Thousands of people should take part in the trial.

[ad_2]
Source link